Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Lykkeslund Bioenergi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   1.9% 1.8% 1.2% 0.6% 0.6% 0.6% 7.6% 7.4%   Credit score (0-100)   71 73 81 97 96 96 32 33   Credit rating   A A A AA AA AA BB BB   Credit limit (kDKK)   1.8 4.6 217.7 2,815.2 5,555.9 4,267.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   8,966 7,040 9,924 21,299 33,867 8,401 0.0 0.0   EBITDA   8,499 6,365 8,571 19,431 30,914 5,264 0.0 0.0   EBIT   4,182 2,028 3,986 14,075 25,207 1,697 0.0 0.0   Pre-tax profit (PTP)   2,953.4 1,345.7 3,608.6 13,823.4 25,114.0 1,751.0 0.0 0.0   Net earnings   2,257.1 1,045.2 2,813.7 10,775.3 19,606.5 1,363.1 0.0 0.0   Pre-tax profit without non-rec. items   2,953 1,346 3,609 13,823 25,114 1,751 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   30,250 26,164 29,795 26,961 37,271 45,869 0.0 0.0   Shareholders equity total   3,774 4,533 7,293 17,668 37,160 38,023 37,851 37,851   Interest-bearing liabilities   0.0 9,872 7,993 8,935 5,964 2,118 0.0 0.0   Balance sheet total (assets)   36,647 37,802 38,236 40,493 62,308 58,243 37,851 37,851   Net Debt   -3,271 8,123 6,134 6,881 -2,455 -5,448 -37,851 -37,851     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,966 7,040 9,924 21,299 33,867 8,401 0.0 0.0   Gross profit growth   61.8% -21.5% 41.0% 114.6% 59.0% -75.2% -100.0% 0.0%   Employees   0 0 0 0 0 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   36,647 37,802 38,236 40,493 62,308 58,243 37,851 37,851   Balance sheet change%   -1.3% 3.2% 1.1% 5.9% 53.9% -6.5% -35.0% 0.0%   Added value   8,498.9 6,365.0 8,570.9 19,430.9 30,562.7 5,264.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -8,028 -8,422 -954 -8,189 4,603 5,032 -45,869 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   46.6% 28.8% 40.2% 66.1% 74.4% 20.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.3% 5.6% 10.6% 35.9% 49.3% 3.3% 0.0% 0.0%   ROI %   22.6% 11.6% 21.4% 58.5% 67.1% 4.4% 0.0% 0.0%   ROE %   85.3% 25.2% 47.6% 86.3% 71.5% 3.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   10.3% 12.0% 19.1% 43.6% 59.6% 65.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -38.5% 127.6% 71.6% 35.4% -7.9% -103.5% 0.0% 0.0%   Gearing %   0.0% 217.8% 109.6% 50.6% 16.0% 5.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   120.8% 14.8% 4.9% 3.7% 2.7% 5.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.8 0.4 0.8 1.0 0.9 0.0 0.0   Current Ratio   1.0 1.1 0.6 1.0 1.2 1.0 0.0 0.0   Cash and cash equivalent   3,271.0 1,749.1 1,859.2 2,053.4 8,418.6 7,566.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   44.5 703.0 -4,548.3 252.4 2,836.1 -562.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 1,755 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 1,755 0 0   EBIT / employee   0 0 0 0 0 566 0 0   Net earnings / employee   0 0 0 0 0 454 0 0